Clinical Trial Update: COMPASSION S3 Post-Approval Study

View source ↗

Summary

This is an active-not-recruiting post-approval study update for Edwards Lifesciences' COMPASSION S3, evaluating outcomes in patients with complex congenital hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Congenital Heart Defect
• Pulmonary Valve Degeneration
• Pulmonary Valve Insufficiency
• Pulmonary Valve Obstruction
• Right Ventricular Outflow Tract Obstruction

Drugs mentioned

• SAPIEN 3 Transcatheter Heart Valve (transcatheter heart valve)

Snippet

Sponsor: Edwards Lifesciences | Conditions: Complex Congenital Heart Defect, Dysfunctional RVOT Conduit | Status: ACTIVE_NOT_RECRUITING